Louis V. Puneky

Comparative analysis of innate immune system function in metastatic breast, colorectal, and prostate cancer patients with circulating tumor cells

Mark F. Santos, Venkat K.R. Mannam, Barbara S. Craft et al. · Experimental and Molecular Pathology · 2014 · 56 citations

Immune Evasion, Cancer Immunosurveillance, Prostate Cancer Patients +11

Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis

Ahmed Ejaeidi, Barbara S. Craft, Louis V. Puneky et al. · Experimental and Molecular Pathology · 2015 · 50 citations

Breast Oncology, Receptor-independent Cxcl10 Production, Cellular Factors +11

Chemotherapy as a palliative treatment in carcinoma of the uterine cervix.

J.T. Thigpen, Ralph Vance, Louis V. Puneky et al. · PubMed · 1995 · 36 citations

A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology

David S. Miller, John A. Blessing, Richard D. Drake et al. · Gynecologic Oncology · 2009 · 34 citations

Phase Ii Evaluation, Gynecological Surgery, Medicine +7

A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: A Gynecologic Oncology Group study

James V. Fiorica, John A. Blessing, Louis V. Puneky et al. · Gynecologic Oncology · 2009 · 29 citations

Cervical Cancer Management, Phase Ii Evaluation, Cervical Cancer +10